TTAX01 (cryopreserved human umbilical cord)

human umbilical cord-derived therapy · BioTissue Holdings, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TTAX01 (cryopreserved human umbilical cord), covering 2020-09-03 to 2020-09-03. Get the full timeline:

Most recent: Clinical Trial Update: Subjects With Non-Healing Venous Leg Ulcers Treated With Standard Care Plus Cryopreserved Human Umbilical Cord (TTAX01) [Phase 2]

See pricing